The intended joint venture between BASF and Domo in France will employ around 650 employees
BASF, Solvay and Domo Chemicals agreed that Domo will acquire the European PA6.6 business from Solvay. This transaction is targeted to close by the end of 2019 and remains subject to the approval of the relevant competition authorities. BASF will acquire the global, non-European PA6.6 business from Solvay including its 50 per cent share in Butachimie’s adipodinitrile (ADN) production according to the agreement signed in September 2017. Subject to the approval of the transaction between Domo and Solvay and final approval of the relevant competition authorities, the transaction between BASF and Solvay is also targeted to close by the end of 2019.
The intended acquisition by BASF now comprises a total of eight production sites in Germany, France, China, India, South Korea, Brazil and Mexico. In France, BASF and Domo will also enter into a joint venture to produce adipic acid. Furthermore, three research and development centres in South Korea, China and Brazil and six technical consultation centres in Asia as well as in North and South America will be transferred from Solvay to BASF.
The purchase price to be paid by BASF on a cash and debt-free basis would amount to €1.3 billion. Solvay’s businesses to be acquired by BASF generated sales of around €1.0 billion in 2018. At closing, approximately 700 Solvay employees will move to BASF. The intended joint venture between BASF and Domo in France will employ approximately 650 employees. BASF is planning to integrate the businesses into its Monomers and Performance Materials divisions.
With this transaction, BASF will benefit from improved access to important growth markets in Asia and South America, enabling the company to improve the close collaboration with local customers. BASF’s product pipeline and product portfolio of engineering plastics will be enhanced as well, which will strengthen the position of the company as a provider of innovative solutions for the transport, construction and consumer goods industries, among others. Through the backward integration into important raw materials such as adipodinitrile (ADN), BASF will be present along the entire value chain for polyamide 6.6 and be able to further increase the capacities to produce polymers.
With its expertise in polymer chemistry, R&D-capabilities and its commitment in developing excipients, BASF creates solutions for Instant & Modified Release, Solubilization, Skin-Delivery and Softgels. BASF offers a variety of chemical raw materials including building blocks, reagents, boranes as well as alcoholates, protective-groups, solvents and high-purity iron salts to meet the specific needs of API-production. The Catalysts portfolio includes fine-chemical catalysts and a full loop of metals-management services. With its human nutrition solutions, BASF offers a broad portfolio for consumers’ needs, including vitamins, carotenoids, plant sterols, emulsifiers and omega-3.
- Advertisement -